Skip to main content
Equibles
KRYS logo

KRYS · Krystal Biotech, Inc. · Share Buybacks

Track KRYS — free

Use KRYS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research KRYS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$305.23 -0.45 (-0.15%) At close · Nov 13 Play latest call Q2 2026 earnings call transcript
S&P 400 member Russell 2000 member Rebalance outlook locked
Market Cap
$9.05B
Shares
29.63M
Volume · Nov 13 110.29K Avg daily vol (3M) 280.28K

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Program Authorized
$400,000,000
as of 2026-10-31

Equity Offering (ATM) Programs

Program Established Capacity Remaining Runs Through
— $150,000,000 — 2026-04-06 expired
Key facts CIK 1711279 CUSIP 501147102 13F (30d) 365 filings 333 filers Visit website Investor relations